If you released a drug that gave 1 in 3000 young men heart damage, with very little likely benefit (either to their demographic or to the population at large), it would either be reindicated or slapped with a black box warning.
If you released a drug that gave 1 in 3000 young men heart damage, with very little likely benefit (either to their demographic or to the population at large), it would either be reindicated or slapped with a black box warning.